2023-17968. Office of the Director, National Institutes of Health; Notice of Meeting

Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the Advisory Committee to the Deputy Director for Intramural Research.

The meeting will be open to the public as a virtual meeting. Individuals who plan to view the virtual meeting and need special assistance or other reasonable accommodations to view the meeting, should notify the Contact Person listed below in advance of the meeting. The meeting will be videocast and can be accessed from the NIH Videocasting and Podcasting website ( http://videocast.nih.gov/​).

Name of Committee: Advisory Committee on Research on Women's Health.

Date: October 18, 2023.

Time: 9:30 a.m. to 4:00 p.m.

Agenda: ORWH Director's Report, Presentation from the Director of the National Institute of General Medical Sciences (NIGMS), Panel discussion with Institutional Development Award (IDeA) Program participants, Presentation of five concepts for Advisory Committee clearance including ORWH Office of Autoimmune Disease Research (ORWH–OADR); Understudied, Underrepresented, and Underreported (U3) Administrative Supplement Program; Gender as a Social and Structural Variable; Women and HIV; and; the Building Interdisciplinary Research Careers in Women's Health (BIRCWH) Program Request for Applications (RFA).

Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).

Contact Person: Samia Noursi, Ph.D., Associate Director Science Policy, Planning, and Analysis, Office of Research on Women's Health, National Institutes of Health, 6707 Democracy Blvd., Room 402, Bethesda, MD 20892, 301–496–9472, [e-mail].

Any member of the public interested in presenting oral comments to the committee may notify the Contact Person listed on this notice at least 10 days in advance of the meetings. Interested individuals and representatives of organizations may submit a letter of intent, a brief description of the organization represented, and a short description of the oral presentation. Only one representative of an organization may be allowed to present oral comments and if accepted by the committee, presentations may be limited to five minutes. Both printed and electronic copies are requested for the record. In addition, any interested person may file written comments with the committee by forwarding their statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person.

Information is also available on the Institute's/Center's home page: https://orwh.od.nih.gov/​, where an agenda and any additional information for the meeting will be posted when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.14, Intramural Research Training Award; 93.22, Clinical Research Loan Repayment Program for Individuals from Disadvantaged Backgrounds; 93.232, Loan Repayment Program for Research Generally; 93.39, Academic Research Enhancement Award; 93.936, NIH Acquired Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, Undergraduate Scholarship Program for Individuals from Disadvantaged Backgrounds, National Institutes of Health, HHS)

Dated: August 16, 2023.

Miguelina Perez,

Program Analyst, Office of Federal Advisory Committee Policy.